Literature DB >> 3339448

Stress-induced malignant hyperthermia in a head-injured patient. Case report.

T Feuerman1, G F Gade, R Reynolds.   

Abstract

Susceptibility to malignant hyperthermia is a rare inherited myopathy. Hypermetabolic crises accompanied by a rise in body temperature to as high as 44 degrees C are the hallmark of malignant hyperthermia episodes. These are triggered by inhalational anesthetic agents or depolarizing muscle-relaxant drugs. A similar condition exists in pigs; however, in addition to drug-induced attacks, episodes of malignant hyperthermia occur in these animals as a result of stress. It has been proposed that stress-induced malignant hyperthermia occurs in man. The present paper presents a case of stress-induced malignant hyperthermia in a 21-year-old man in whom the inciting stress was a head injury.

Entities:  

Mesh:

Year:  1988        PMID: 3339448     DOI: 10.3171/jns.1988.68.2.0297

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Paroxysmal autonomic instability with dystonia.

Authors:  Sheila Srinivasan; C C Tchoyoson Lim; Umapathi Thirugnanam
Journal:  Clin Auton Res       Date:  2007-07-16       Impact factor: 4.435

2.  Junctional membrane Ca2+ dynamics in human muscle fibers are altered by malignant hyperthermia causative RyR mutation.

Authors:  Tanya R Cully; Rocky H Choi; Andrew R Bjorksten; D George Stephenson; Robyn M Murphy; Bradley S Launikonis
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-23       Impact factor: 11.205

3.  Fatal fever of unknown origin in acute cervical spinal cord injury: five cases.

Authors:  Fatma Ulger; Ahmet Dilek; Deniz Karakaya; Alparslan Senel; Binnur Sarihasan
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

4.  Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series.

Authors:  Jacobo Lester; Gerardo Esteban Alvarez-Resendiz; Enrique Klériga; Fernando Videgaray; Gerardo Zambito
Journal:  Neurol Ther       Date:  2018-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.